Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2010
08/26/2010US20100215659 Functionalized surgical adhesives
08/26/2010US20100215658 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215656 Deletions in domain ii of pseudomonas exotoxin a that remove immunogenic epitopes
08/26/2010US20100215655 Angiogenesis-inhibiting chimeric proteins and the use
08/26/2010US20100215654 Methods of treating Osteoarthritis with IL-6 Antagonists
08/26/2010US20100215653 Methods of treating neoplastic, autoimmune and inflammatory diseases
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215651 Humanized antibodies that bind to CD19 and their uses
08/26/2010US20100215650 Methods of treating dementia using a gm-csf antagonist
08/26/2010US20100215649 Antibodies for norovirus
08/26/2010US20100215648 Detecting Agent and Therapeutic Agent for Highly Malignant Breast Cancer
08/26/2010US20100215647 Immunological Compositions as Cancer Biomarkers and/or Therapeutics
08/26/2010US20100215646 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo) containing different lengths of palindromic segments
08/26/2010US20100215645 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of any of SEQ ID NOS:10,916-49,582 and 50,231
08/26/2010US20100215644 Analysis of nodes in cellular pathways
08/26/2010US20100215642 Synthetic rna-based agonists of tlr7
08/26/2010US20100215641 Screening method for compounds that reduce er stress
08/26/2010US20100215640 Method for inhibiting cellular activation by insulin-like growth factor-1
08/26/2010US20100215639 Chlamydia Pneumoniae Associated Chronic Intraocular Disorders and Treatment Thereof
08/26/2010US20100215638 Method for treatment of prostate cancer and screening of patients benefiting from said method
08/26/2010US20100215637 Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010US20100215584 Compositions and methods of modulating the taste and smell receptors and screening methods therefore
08/26/2010US20100215576 Diagnosis and treatment of neuroectodermal tumors
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010US20100212667 Drug capsules for dry powder inhalers
08/26/2010CA2789515A1 Treatment of chronic inflammatory conditions
08/26/2010CA2786891A1 Immunopotentiating composition and process for producing same
08/26/2010CA2767752A1 Improved anti-serum albumin binding variants
08/26/2010CA2753294A1 Proproteins and methods of use thereof
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/26/2010CA2753082A1 Recombinant viral vectors
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2752815A1 Antibodies to clostridium difficile toxins
08/26/2010CA2752809A1 Inactivated dengue virus vaccine with aluminium-free adjuvant
08/26/2010CA2752584A1 Specific binding proteins and uses thereof
08/26/2010CA2752171A1 Method for inhibiting neurodegeneration
08/26/2010CA2751477A1 Antibody molecules having specificity for human ox40
08/26/2010CA2750985A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010CA2750980A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010CA2750477A1 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/26/2010CA2750136A1 Live attenuated vaccines
08/26/2010CA2739905A1 Mimotopes of hiv env
08/25/2010EP2221384A1 Method for production of antibody
08/25/2010EP2221375A1 Methods and compositions for diagnosis and treatment of cancer
08/25/2010EP2221374A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
08/25/2010EP2221368A1 West nile virus vaccine, and method for production thereof
08/25/2010EP2221316A1 Anti-CD19 antibody therapy for autoimmune disease
08/25/2010EP2221064A1 Humanized antibodies that recognize beta amyloid peptide
08/25/2010EP2221063A1 Methods and compositions for diagnosis and treatment of cancer
08/25/2010EP2221062A1 Novel adjuvant
08/25/2010EP2220493A1 Novel surface protein mutants of the hepatitis b virus hbv surface antigen (hbsag)
08/25/2010EP2220241A2 Simian e adenoviruses sadv-39, -25.2, -26, -30, -37, and -38
08/25/2010EP2220122A2 Humanized antibodies against tl1a
08/25/2010EP2220119A2 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin
08/25/2010EP2220118A2 Wise binding antibodies and epitopes
08/25/2010EP2220116A1 Compositions and methods for the therapy and diagnosis of influenza
08/25/2010EP2220114A1 Anti-vegf antibodies
08/25/2010EP2219675A1 Formulations for taci-immunoglobulin fusion proteins
08/25/2010EP2219674A1 Taci-immunoglobulin fusion proteins for treatment of optic neuritis
08/25/2010EP2219673A1 Taci-immunoglobulin fusion proteins for treatment of relapsing multiple sclerosis
08/25/2010EP2219672A1 Anti-vegf antibody compositions and methods
08/25/2010EP2219670A2 Universal vaccine for the treatment and prophylaxis of lyme disease for human and veterinary use and method of its manufacture
08/25/2010EP2219669A1 Compositions and methods for treatment of autoimmune and allergic diseases
08/25/2010EP2219668A1 Binding epitopes for g250 antibody
08/25/2010EP2219667A2 Thomsen-friedenreich disaccharide modified immunogen (tfd), preparation procedure, compositions comprising it, uses, and treatment methods
08/25/2010EP2219654A2 Treatment of inflammatory diseases
08/25/2010EP2219602A1 Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
08/25/2010EP1789083B1 Prevention of allergy in children
08/25/2010EP1594436B1 Mutated neublastin
08/25/2010EP1469882B1 Treatment of nervous system diseases with goat serum
08/25/2010EP1404367B1 Use of polyclonal anti-hiv goat serum as a therapeutic agent
08/25/2010EP1339738B1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
08/25/2010EP1228208B1 36p6d5: secreted tumor antigen
08/25/2010EP1194580B2 In vitro reconstitution of segmented negative-strand rna viruses
08/25/2010EP1100529B2 Thymosin beta 4 promotes wound repair
08/25/2010CN201561887U Device for preparing polypeptide vaccine standard for treating hepatitis B
08/25/2010CN1829917B Evaluation of adjuvanted vaccines
08/25/2010CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
08/25/2010CN101815725A anti cd37 antibodies
08/25/2010CN101815724A aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
08/25/2010CN101815532A Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient
08/25/2010CN101815531A Novel cellular factor-containing solution compositions
08/25/2010CN101815530A Therapeutic antibody purification method and method of use
08/25/2010CN101815529A Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
08/25/2010CN101815528A vaccines containing canine parvovirus genetic variants
08/25/2010CN101815527A Capsule composition for use as immunogen against campylobacter jejuni
08/25/2010CN101815505A Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
08/25/2010CN101812473A Human papillomavirus and chlamydia trachomatis chimeric nucleic acid vaccine and applications thereof
08/25/2010CN101812468A Method for preparing rabies virus antigen by chloroplast
08/25/2010CN101812424A Thymine auxotrophic bacillus anthracis and application thereof
08/25/2010CN101812134A Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
08/25/2010CN101812133A Receptor, the use thereof, and mouse antibodies
08/25/2010CN101812132A Humanized neutralizing antibody (RVFab3) against rabies virus glycoprotein
08/25/2010CN101812131A Humanized neutralizing antibody (RVFab8) against rabies virus glycoprotein
08/25/2010CN101812130A Humanized neutralizing antibody (RVFab5) against rabies virus glycoprotein
08/25/2010CN101810857A New application of anti-phosphatidylserine receptor antibody on treating cancer
08/25/2010CN101810847A Inflammation-inhibiting compounds
08/25/2010CN101220086B Extraction, purification process for yersinia pestis natural F1 antigen
1 ... 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 ... 1823